India: Who says that the Bhaijaan of Bollywood does not face rejection? Salman Khan’s offer of a whopping Rs 2
MUMBAI: Mylan Pharmaceuticals launched HepBest 25 mg (tenofovir alafenamide, TAF), Once a day tablet for the treatment of chronic hepatitis
did not conform to the fielding hopes of India during the five-wicket defeat in the fourth ODI against South Africa.
Check out technology changing the life.
South Africa-based Life Healthcare Group Holdings is looking to sell its 49.7 percent stake in Max Healthcare, Bloomberg reported on